Verena Staedtke Selected Research

Verena Staedtke Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 07/2010
7	Brain Neoplasms (Brain Tumor) 01/2022 - 09/2011
5	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 06/2011
5	Glioma (Gliomas) 01/2021 - 09/2011
4	Medulloblastoma 08/2015 - 07/2010
3	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2020 - 01/2017
3	Cytokine Release Syndrome 01/2020 - 12/2018
2	Neurofibrosarcoma (MPNST) 01/2020 - 01/2019
2	Infections 12/2018 - 12/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	COVID-19 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Brain Abscess (Abscess, Brain) 01/2018
1	Tuberous Sclerosis (Bourneville's Disease) 01/2017
1	Epilepsy (Aura) 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Seizures (Absence Seizure) 01/2017
1	Sturge-Weber Syndrome (Sturge-Kalischer-Weber Syndrome) 01/2017
1	Neurocutaneous Syndromes (Phakomatoses) 01/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Colonic Neoplasms (Colon Cancer) 10/2016
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2016
1	Adenoma (Adenomas) 10/2016
1	Polyps 10/2016
1	Edema (Dropsy) 03/2015
1	Hypoxia (Hypoxemia) 03/2015
1	Enterobiasis 09/2011
1	Parasitic Diseases (Parasitic Disease) 09/2011

Drug/Important Bio-Agent (IBA)

6	Mebendazole (Anti-Worm)FDA Link 01/2021 - 09/2011
3	Pharmaceutical PreparationsIBA 01/2021 - 06/2011
2	Contrast MediaIBA 01/2022 - 01/2018
2	AntibodiesIBA 01/2021 - 12/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 03/2015
2	Antiparasitic Agents (Antiparasitics)IBA 08/2015 - 09/2011
1	Dichlorodiphenyl Dichloroethylene (DDE)IBA 01/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2022
1	alpha-1 Adrenergic Receptors (alpha 1 Adrenergic Receptor)IBA 11/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	AnthelminticsIBA 01/2021
1	Guanosine Triphosphate (GTP)IBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020
1	axicabtagene ciloleucelIBA 01/2020
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2020
1	ras ProteinsIBA 01/2019
1	Neurofibromin 1 (Neurofibromin)IBA 01/2019
1	alpha-Methyltyrosine (Metirosine)FDA Link 12/2018
1	CatecholaminesIBA 12/2018
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2018
1	Dextrans (Dextran)FDA Link 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2017
1	GelatinIBA 04/2017
1	Peptides (Polypeptides)IBA 01/2017
1	HydrogelsIBA 01/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	trans-sodium crocetinate (crocetin)IBA 01/2017
1	Sulindac (Copal)FDA LinkGeneric 10/2016
1	Drug CombinationsIBA 10/2016
1	Investigational DrugsIBA 08/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	ElacridarIBA 08/2015
1	TabletsIBA 08/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2015
1	HhAntag691IBA 04/2015
1	Phosphotransferases (Kinase)IBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	podocalyxinIBA 01/2013
1	Otx Transcription FactorsIBA 11/2012
1	benzimidazoleIBA 09/2011
1	FenbendazoleIBA 09/2011
1	Drug CarriersIBA 01/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2010
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 07/2010

Therapy/Procedure

12	Therapeutics 01/2022 - 07/2010
2	Immunotherapy 12/2018 - 08/2016
2	Drug Therapy (Chemotherapy) 01/2017 - 08/2016
1	Precision Medicine 01/2018
1	Intraperitoneal Injections 01/2018
1	Aftercare (After-Treatment) 12/2013